Literature DB >> 15892119

Rho GTPase expression in tumourigenesis: evidence for a significant link.

Teresa Gómez del Pulgar1, Salvador A Benitah, Pilar F Valerón, Carolina Espina, Juan Carlos Lacal.   

Abstract

Rho proteins belong to the small GTPases superfamily. They function as molecular switches that, in response to diverse stimuli, control key signaling and structural aspects of the cell. Although early studies proposed a role for Rho GTPases in cellular transformation, this effect was underestimated due to the fact that no genetic mutations affecting Rho-encoding genes were found in tumors. Recently, it has become evident that Rho GTPases participate in the carcinogenic process by either overexpression of some of the members of the family with oncogenic activity, downmodulation of other members with suggested tumor suppressor activity, or by alteration of upstream modulators or downstream effectors. Thus, alteration of the levels of expression of different members of the family of Rho GTPases has been detected in many types of human tumors leading to a great interest in the cellular effects elicited by these oncoproteins. This essay reviews the current evidence of dysregulation of Rho signaling by overexpression in human tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892119     DOI: 10.1002/bies.20238

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  97 in total

1.  High-throughput flow cytometry bead-based multiplex assay for identification of Rho GTPase inhibitors.

Authors:  Zurab Surviladze; Susan M Young; Larry A Sklar
Journal:  Methods Mol Biol       Date:  2012

2.  Arachidonic acid stimulates formation of a novel complex containing nucleolin and RhoA.

Authors:  Melissa C Garcia; Jason Williams; Katina Johnson; Kenneth Olden; John D Roberts
Journal:  FEBS Lett       Date:  2011-02-01       Impact factor: 4.124

3.  The atypical Rho GTPase Wrch1 collaborates with the nonreceptor tyrosine kinases Pyk2 and Src in regulating cytoskeletal dynamics.

Authors:  Aino Ruusala; Pontus Aspenström
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

4.  Involvement of RhoA, ROCK I and myosin II in inverted orientation of epithelial polarity.

Authors:  Wei Yu; Annette M Shewan; Paul Brakeman; Dennis J Eastburn; Anirban Datta; David M Bryant; Qi-Wen Fan; William A Weiss; Mirjam M P Zegers; Keith E Mostov
Journal:  EMBO Rep       Date:  2008-07-25       Impact factor: 8.807

5.  Inhibition of migration and invasion of colorectal cancer cells via deletion of Rac1 with RNA interference.

Authors:  Shi-Yi Zhao; Yan Sun; Zhuo-Sheng Lai; Qing-Zhen Nan; Kang Li; Zhen-Shu Zhang
Journal:  Mol Cell Biochem       Date:  2008-11-15       Impact factor: 3.396

Review 6.  Small Rho GTPases in the control of cell shape and mobility.

Authors:  Arun Murali; Krishnaraj Rajalingam
Journal:  Cell Mol Life Sci       Date:  2013-11-26       Impact factor: 9.261

Review 7.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

Review 8.  Rho GTPases: Regulation and roles in cancer cell biology.

Authors:  Raquel B Haga; Anne J Ridley
Journal:  Small GTPases       Date:  2016-09-14

9.  Constitutively active RhoA inhibits proliferation by retarding G(1) to S phase cell cycle progression and impairing cytokinesis.

Authors:  Pierre Morin; Cristina Flors; Michael F Olson
Journal:  Eur J Cell Biol       Date:  2009-06-09       Impact factor: 4.492

10.  Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients.

Authors:  H-B Wang; H-C Yan; Y Liu
Journal:  Clin Transl Oncol       Date:  2015-10-26       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.